BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.
Beryl Drugs Ltd: key numbers
- Share price
- ₹25.94
- Market cap
- ₹13.16 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 21.1×Sector 42.0×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beryl Drugs Ltd
All →Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Annual Report
Beryl Drugs Ltd has submitted its 33rd Annual Report for the financial year 2025-26, scheduled for its upcoming Annual General Meeting.
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Other board meeting date announcements
All →KS Smart Technologies Board Meeting Date
KS Smart Technologies will hold a board meeting on 13 November 2026 to approve unaudited results. The trading window stays closed until results are disseminated.
BharatRohan Airborne Innovations Board Meeting Date
BharatRohan Airborne Innovations gave notice of a board meeting on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The meeting has not yet been held and no results are attached.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results publication.
Jungle Camps India Board Meeting Date
Jungle Camps India schedules a board meeting on November 13, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 15.
Zetwerk Manufacturing Businesses Board Meeting Date
Zetwerk Manufacturing will hold a board meeting on 13 November 2026 to consider September quarter results. Trading window stays closed until 48 hours after results are public.
Lovable Lingerie Board Meeting Date
Lovable Lingerie will hold a board meeting on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window is closed from 1 October 2026 until 16 November 2026.